Ask the Expert

	Performance benchmarks Dr. Fredric J. Cohen discusses procedure-related benchmarks to inform and streamline study design. More >>		The right connection Across the global pharmaceutical industry, companies are waking up to the shortcomings of new drug applications. The cost of research and development (R&D) is rising, while the approval rate of innovative new drugs is declining. Joe Herring, Chairman and CEO of Covance, talks about the role outsourcing plays. More >>
	The commercialization of companion diagnostics Companion diagnostics are the hallmark of personalized medicine and represent a growing industry trend. Fueled by declining NDA submissions amidst record R&D spending, the pharmaceutical industry has shifted its focus away from the blockbuster model to targeted therapies. The use of pharmacogenetic testing for drug salvage, re-positioning of existing compounds, and market differentiation continues to increase. More >>

Previous Ask the Experts

Forging Ahead despite Choppy Seas

Market times, believe Dr. Pia Nicolini and Dr. Stephanie J. Oscarson, have become more challenging than ever. How can the industry help to preserve the integrity of market research?

More >>

Expanding into Biotherapeutics
Biotherapeutics, believes Dr. Tim Riley, are growing rapidly – and Waters’ mass spectrometry systems are geared at controlling their quality and efficacy.
More >>

Faster, Higher, Stronger
What does drug discovery have in common with the Olympics? NGP asked Pharmatest’s Rami Käkönen about competitiveness and the preclinical games.
More >>

RFID Tag Data Security Infrastructure
For the pharmaceutical industry to create a secure supply chain using RFID technology at the item-level, it needs a broader and more flexible approach – one that encompasses all stakeholder requirements and provides a range of implementation options.
More >>

Build or buy critical eClinical applications?
Author: Fredric J. Cohen, M.D.
More >>

Time tested marketing research techniques work in the pharma industry
Tara Marotti, Vice President at Burke explains how market and online research can serve a critical function for the pharmaceutical industry
More >>

Integrated Talent Management- A comprehensive approach to driving organizational performance.
More >>

Blood pressure monitoring
Dr. Ian Wilkinson and Dr. Carmel McEniery from Addenbrooke’s Hospital, University of Cambridge UK, explain why non-invasive central blood pressure monitoring is a vital new resource in research, clinical trials and drug therapy management.
More >>

Ask the Expert: Considerations in branding strategy development
By Kathy Magnuson, EVP and Managing Director, Brand Pharm
More >>

Ask the expert: Atomic theory
Unit 7’s Loreen Babcock explains the ‘Atomic Theory’ in Relationship Marketing Building - the mastery to connect, unite, react and interact with consumers.
More >>

Ask the expert: opinion leadership – a spectrum of influence which shapes the marketplace

By Neil Croft, Manager of Brand Solutions, MMR International

More >>

Consumer empowerment

Jim Nail on how to embrace and use consumer empowerment in today’s social media.

More >>

Ask the expert: quantity, quality and timing in drug discovery
With William Janzen, President & COO at Amphora Discovery Corporation
More >>

Ask the Expert: MicroRNAs – keep your research on track
The use of new technologies to overcome many of the initial challenges in microRNA research will allow comprehensive studies of microRNA expression patterns and identification of microRNA biomarkers in cancer and other diseases over the next few years.
More >>

Ask the Expert: Lab-on-a-chip, have it their way or your way?
Has lab-on-a-chip design become pounding your assay design to fit existing structures or can you get a biochip that is your assay design as you developed it? By Stephen F. Malin, CFD Research Corporation
More >>

Ask the expert: establishing a brand to improve marketing effectiveness
By Kathy Magnuson, EVP, Managing Director, Brand Pharm
More >>

Ask the Expert: Leveraging medical education to improve sales force effectiveness
By Tracy Doyle, Phoenix Group
More >>

Ask the Expert: How do I maximize my manufacturing efficiency?
With GlaxoSmithKline’s David Pulman, President, Global Manufacturing & Supply.
More >>

Ask the expert: How to… manage pharma’s mid-life crisis
Kathy Magnuson, EVP and Managing Director for Brand Pharm, looks at managing the mid-lifecycle crisis in pharmaceutical promotion.
More >>

Boomer retirement, Globalisation, Outsourcing – where’s your Intellectual Capital?
“You would have to have been living on the moon over the last few years not to know that baby boomers are fast approaching retirement age.”
More >>

Ask the Experts: The Communicator
Talking with John Benbrook, President, MMG, (Matthews Media Group).
More >>

Ask the expert: How to: focus on effective training and development
Dr Joel Dobbs is Executive-In-Residence and Program Director for Pharmaceutical Management at the Stevens Institute of Technology examines the challenges pharmaceutical companies face in regards to training and development of their staff and leaders.
More >>

Ask the expert
How to: juggle clinical development, with Fast Track Systems’ Ed Seguine.
More >>

Expert’s forum: Advances in drug discovery
GE Healthcare’s Kevin Daish and Joseph P. Brown of LifeSpan BioSciences talk latest developments.
More >>

LIMS: an executive perspective
NGP talks with Dave Champagne, Vice President and General Manager of Thermo’s Informatics Business, about the future of laboratory information management systems.
More >>

Technology chips in to help science
By Neil Davey (NGP)
Microchips have revolutionised the electronics industry. Now they are set to do the same to chemical laboratories.
More >>

Priorities in R&D: Pushing things forward
NPG speaks exclusively to Dr Robert Ruffolo, Jr.,Ph.D. President at Wyeth Research and Stephen Lederer, Senior Director at Pfizer about their current priorities in R&D including current focus areas, drivers and the role of new centres of excellence.
More >>

A chance for pharmaceutical drug development
Frank Gebhardt, Ph.D., Head of Target Validation, atugen AG, Berlin, Germany, looks further at the development and potential for RNAi.
More >>

Onwards and upwards
We spoke to Len Goren, Vice President of Sartorius BBI Systems Inc, to find out how the company is building on the successes of the past and addressing some of the key issues affecting manufacturers today and in the future.
More >>

Playing catch up
When it comes to maximizing the ROI of promotional activities, the industry has much to learn.
More >>

Looking into the future of RFID
NGP puts some questions to Laura Ramos Vice President, Forrester Research
More >>

'till death do us part'
Deciding whether or not to outsource and finding the right partner can be difficult.
More >>

Fighting fear
Royanna Chappell, VP of RFID and Emerging Applications at Red Prairie, looks at how RFID can help to reassure the pharma industry.
More >>

Appliance of science
NGP speaks to Lisa Ensign Netregulus Director of Study and Biostatistical Solutions about the importance of having the right applications
More >>

RNAi libraries
High throughput transfection with Nucleofector technology.
More >>

On the record
The results are in for this year?s Liquent Regulatory Affairs Trends Survey, widely recognized as the premier benchmark of global regulatory submissions trends. Vice President of Product Strategy and Marketing, Jim Nichols presents the key findings.
More >>

Biology-aware data warehouses: the next discovery 'appliance'
A tera-scale data warehouse appliance with data types specific to bioinformatics can help solve the processing bottleneck for genetic researchers. By Bill Blake, Senior Vice President of product development for Netezza.
More >>